Grant: Operating Grant
University of Toronto
$384,468.00
Novel docosahexaenoic acid derived mediators in the resolution of neuroinflammation
FY 2013-14
Summary
Inflammation in the brain, also called neuroinflammation believed to contribute to increased risk of several brain disorders including major depression and Alzheimer's disease. Many different types of studies examining people who eat fish, which is rich in a fatty acid called docosahexaenoic acid (DHA)demonstrate that it reduces the risk or can even treat several of these brain disorders. However, it is unknown how DHA works in these disorders. While using a mouse model of neuroinflammation, we have shown that increasing brain DHA, with diet or genetic approaches lowers brain inflammation. Furthermore, we have discovered a metabolite of DHA that is formed when brain inflammations starts to decrease. We think that this new metabolite of DHA may be the mechanism by which DHA lowers brain inflammation. If this is true, this work could lead to potent new methods to treat brain inflammation and brain disorders.
Department
Program
Operating Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
304729
Name
Bazinet Richard P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
Novel docosahexaenoic acid derived mediators in the resolution of neuroinflammation
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$384,468
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Arachidonic Acid; Diet; Docosahexaenoic Acid; Lipopolysaccharide; Mouse; Neuroinflammation; Nutrition; Resolution
Abstract
Inflammation in the brain, also called neuroinflammation believed to contribute to increased risk of several brain disorders including major depression and Alzheimer's disease. Many different types of studies examining people who eat fish, which is rich in a fatty acid called docosahexaenoic acid (DHA)demonstrate that it reduces the risk or can even treat several of these brain disorders. However, it is unknown how DHA works in these disorders. While using a mouse model of neuroinflammation, we have shown that increasing brain DHA, with diet or genetic approaches lowers brain inflammation. Furthermore, we have discovered a metabolite of DHA that is formed when brain inflammations starts to decrease. We think that this new metabolite of DHA may be the mechanism by which DHA lowers brain inflammation. If this is true, this work could lead to potent new methods to treat brain inflammation and brain disorders.
Competitiondate
201403
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bazinet, Richard P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $384,468~ $0~